Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring

NCT06873828 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University